Medindia LOGIN REGISTER
Medindia
Advertisement

Positive Findings of Dasotraline in ADHD in Children Aged 6-12

by Ramya Rachamanti on February 5, 2019 at 2:27 PM
Positive Findings of Dasotraline in ADHD in Children Aged 6-12

Dasotraline showed significant improvement in efficacy compared to placebo at week 1 and throughout the study for children aged 6 to 12 years with attention deficit hyperactivity disorder (ADHD) which could be a promising new treatment.

A detailed description of the trial design and the results is published in the Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Advertisement


Robert Goldman, PhD, Sunovion Pharmaceuticals (Marlborough, MA and Fort Lee, NJ), and colleagues from Kennedy Krieger Institute/Johns Hopkins University (Baltimore, MD), New York University Langone Medical Center (New York, NY), and Massachusetts General Hospital (Boston, MA) coauthored the article entitled "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial."

The researchers conducted a 6-week trial in which children with a diagnosis of ADHD received a once-daily morning dose of dasotraline (2mg or 4mg) or placebo. The primary endpoint to determine efficacy was an ADHD rating scale that determined change from baseline. Treatment with dasotraline 4g/day only was associated with significant improvement in efficacy.
Advertisement

Dasotraline also showed significant improvement for some secondary efficacy endpoints, including measures of hyperactivity and inattentiveness. The study also assessed the safety of dasotraline treatment and performed subgroup analysis to look for differences in safety and efficacy across subgroups such as age, gender, and use of other treatments for ADHD.

"Over four million children suffer from ADHD. The investigation of new, safe treatments with less side effects is needed for this patient group," says Harold S. Koplewicz, MD, Editor-in-Chief of the Journal of Child and Adolescent Psychopharmacology and President of the Child Mind Institute in New York.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Child Health News

Group B Streptococcus Threat to Newborns
The presence of Streptococcus in the placenta was associated with a two- to three-fold increase in the probability of neonatal unit admission.
Can Maternal Discrimination Influence Baby's Brain Development?
Facing discrimination and acculturating during pregnancy could not only affect the mother but also potentially harm the baby's brain health.
Respiratory Infections Spike Among Kids in China
A number of pathogens are to blame for the rise in childhood acute respiratory diseases, according to Chinese health officials.
Measles Immunization Gaps in India Exposed
World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) highlight the deficiencies in disease surveillance efforts.
Gender-Specific Brain Injury Interventions for Newborns
Need for gender-specific interventions in brain injuries has been highlighted by a new study due to its higher prevalence in newborn boys.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Positive Findings of Dasotraline in ADHD in Children Aged 6-12 Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests